// App-Quantinova.ai

11539 : Serum microRNAs/enriched pathways in lung cancer 1-4 years before diagnosis: A pilot study from the HUNT Biobank, Norway.

Researchers

Presenter

  • Oluf D. Roe

Principal Investigators

  • Maria Markaki

  • Robin Mjelle

  • Pal Strom

  • Ioannis Tsamardinos

  • Vincenzo Lagani

Medical Centers

  • Cancer Clinic, Levanger Hospital, Levanger, Norway

  • Department of Computer Science, University of Crete, Heraklion, Greece

  • Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

  • Department of Computer and Information Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Locations

  • Norway

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma

  • Small cell lung cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved